Nianyong Chen
Overview
Explore the profile of Nianyong Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
691
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su S, Liang L, Liu Z, Wang L, Zhang T, Chen N
Int J Surg
. 2025 Mar;
111(1):1090-1100.
PMID: 40053807
Narrowed or stenotic airways are frequently encountered in emergency practice. Neck and chest tumors-caused airway obstruction usually follow a severe clinical course, necessitating urgent ventilation as a bridge to perform...
2.
Mu M, Wang G, Chen B, Li H, Feng C, Fan R, et al.
J Mater Chem B
. 2025 Feb;
13(11):3685-3699.
PMID: 39981850
Oncolytic viruses (OVs) are promising for cancer treatment as they specifically replicate in tumor cells. However, the systemic delivery of OVs still faces the challenges of poor tumor targeting, short...
3.
Lin J, Qu S, Yang K, Zhang T, Bai Y, Wu J, et al.
Cancer Lett
. 2025 Feb;
613:217513.
PMID: 39892704
Treatment options for recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) are limited, especially for patients who progress after immune checkpoint inhibitor (ICI) therapy. This phase Ib...
4.
Yan Q, Li S, Zhang L, Tang S, Chen N, He L
BMC Geriatr
. 2024 Nov;
24(1):956.
PMID: 39550570
Background: Epithelioid Hemangioendothelioma (EHE) is an extremely rare malignancy originating from endothelial cells, with an incidence rate of less than 1/100,000. To date, there have been no documented cases of...
5.
Zhang S, Zeng N, Yang J, Han J, He J, Duan B, et al.
Head Neck
. 2024 Nov;
47(3):917-927.
PMID: 39501710
Objective: To investigate the failure patterns of recurrent nasopharyngeal carcinoma (NPC), especially to identify the relationship between the recurrent-prone anatomic structures and the tumor regression sites after the introduction of ...
6.
Yan Q, Li S, He L, Chen N
Front Immunol
. 2024 Oct;
15:1476365.
PMID: 39372398
Background: Tumor-infiltrating lymphocytes (TILs) have demonstrated potential as prognostic biomarkers across various cancer types. However, their prognostic implications in non-small cell lung cancer (NSCLC) remain ambiguous. Methods: An exhaustive electronic...
7.
Mu M, Chen B, Li H, Fan R, Yang Y, Zhou L, et al.
J Control Release
. 2024 Sep;
375:733-744.
PMID: 39332776
Ferroptosis primarily relies on reactive oxygen (ROS) production and lipid peroxide (LPO) accumulation, which opens up new opportunities for tumor therapy. However, a standalone ferroptosis process is insufficient in inhibiting...
8.
Zhou Y, Zhang S, Qiu G, Wang X, Yonemura A, Xu H, et al.
J Clin Invest
. 2024 Sep;
134(22).
PMID: 39325536
Activated mTORC2/AKT signaling plays a role in hepatocellular carcinoma (HCC). Research has shown that TSC/mTORC1 and FOXO1 are distinct downstream effectors of AKT signaling in liver regeneration and metabolism. However,...
9.
Xiao S, Mu M, Feng C, Pan S, Chen N
J Nanobiotechnology
. 2024 Sep;
22(1):536.
PMID: 39227831
Adverse effects and multidrug resistance remain significant obstacles in conventional cancer therapy. Nanomedicines, with their intrinsic properties such as nano-sized dimensions and tunable surface characteristics, have the potential to mitigate...
10.
Wan X, Liu Y, Peng Y, Wang J, Yan S, Zhang L, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(36):e2403161.
PMID: 39049720
Nasopharyngeal carcinoma (NPC), a squamous cell carcinoma originating in the nasopharynx, is a leading malignancy in south China and other south and east Asia areas. It is frequently associated with...